These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19068566)

  • 21. Comparative assessment for medications and devices: apples and oranges?
    Ramsey S
    Value Health; 2010 Jun; 13 Suppl 1():S12-4. PubMed ID: 20618788
    [No Abstract]   [Full Text] [Related]  

  • 22. Minimum requirements for approval of a drug in status epilepticus.
    Baulac M; Navarro V
    Epilepsia; 2009 Dec; 50 Suppl 12():77-8. PubMed ID: 19941535
    [No Abstract]   [Full Text] [Related]  

  • 23. Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS.
    Kim J; Ross JS; Kapczynski A
    JAMA; 2018 Jan; 319(1):21-22. PubMed ID: 29117365
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reproducibility of biomedical research: Quo vadis?].
    Dal-Ré R; Bernad A; Garesse R
    Med Clin (Barc); 2016 May; 146(9):408-12. PubMed ID: 26776486
    [No Abstract]   [Full Text] [Related]  

  • 25. A Parallel Universe of Clinical Trials.
    Lo B
    N Engl J Med; 2018 Jul; 379(2):101-103. PubMed ID: 29996077
    [No Abstract]   [Full Text] [Related]  

  • 26. Industry looks to buck bias in emerging 'adaptive' designs.
    Torres C
    Nat Med; 2010 Jun; 16(6):619. PubMed ID: 20526301
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of Katrina on clinical research: lessons learned.
    Slakey DP
    J La State Med Soc; 2007; 159(3):166-8. PubMed ID: 17694937
    [No Abstract]   [Full Text] [Related]  

  • 28. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later.
    Avorn J; Kesselheim A; Sarpatwari A
    N Engl J Med; 2018 Sep; 379(12):1097-1099. PubMed ID: 30231220
    [No Abstract]   [Full Text] [Related]  

  • 29. Pragmatism, dynamism and flexibility in research and clinical practice.
    Acharya G
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):345-6. PubMed ID: 25761442
    [No Abstract]   [Full Text] [Related]  

  • 30. Characteristics of orphan drug applications that fail to achieve marketing approval in the USA.
    Heemstra HE; Leufkens HG; Rodgers RP; Xu K; Voordouw BC; Braun MM
    Drug Discov Today; 2011 Jan; 16(1-2):73-80. PubMed ID: 21094692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving transparency of scientific reporting to increase value and reduce waste in mental health research.
    Catalá-López F; Moher D; Tabarés-Seisdedos R
    Rev Psiquiatr Salud Ment; 2016; 9(1):1-3. PubMed ID: 26896001
    [No Abstract]   [Full Text] [Related]  

  • 32. Call for a new approach to the process of clinical trials and drug registration.
    Jones TC
    BMJ; 2001 Apr; 322(7291):920-3. PubMed ID: 11302912
    [No Abstract]   [Full Text] [Related]  

  • 33. A US Food and Drug Administration perspective on evaluating medical products for Ebola.
    Russek-Cohen E; Rubin D; Price D; Sun W; Cox E; Borio L
    Clin Trials; 2016 Feb; 13(1):105-9. PubMed ID: 26768565
    [No Abstract]   [Full Text] [Related]  

  • 34. Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
    Hecker SJ; Preston C; Foote M
    Biotechnol Annu Rev; 2003; 9():269-77. PubMed ID: 14650931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical nanotechnology: shortening clinical trials and regulatory pathways?
    Ferrari M; Downing G
    BioDrugs; 2005; 19(4):203-10. PubMed ID: 16128604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming the Activation of Clinical Trials.
    Watters JT; Pitzen JH; Sanders LJ; Bruce VNM; Cornell AR; Cseko GC; Grace JS; Kwon PS; Kukla AK; Lee MS; Monosmith MD; Myren JD; Kottschade RS; Shaft MN; Weis JJA; Welter JC; Bharucha AE
    Clin Pharmacol Ther; 2018 Jan; 103(1):43-46. PubMed ID: 29105757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient drug approval and monitoring must rely on sound regulatory science.
    Meagher EA; Fitzgerald GA
    Nat Med; 2011 Dec; 17(12):1535. PubMed ID: 22146443
    [No Abstract]   [Full Text] [Related]  

  • 38. How can we regulate medicines better?
    Garattini S; Bertele' V
    BMJ; 2007 Oct; 335(7624):803-5. PubMed ID: 17947785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indian government approves 50 clinical trials in one day.
    Kay M
    BMJ; 2013 Jul; 347():f4455. PubMed ID: 23857992
    [No Abstract]   [Full Text] [Related]  

  • 40. The needs of the few.
    Nature; 2010 Jul; 466(7303):160. PubMed ID: 20613796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.